The post Mantle – Examining if MNT’s December strength can survive market fear appeared on BitcoinEthereumNews.com. Mantle was one of the handful of tokens in theThe post Mantle – Examining if MNT’s December strength can survive market fear appeared on BitcoinEthereumNews.com. Mantle was one of the handful of tokens in the

Mantle – Examining if MNT’s December strength can survive market fear

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Mantle was one of the handful of tokens in the top 50 crypto assets that had a positive performance over the past week. MNT was up 9.13% in a week and 1.37% in 24 hours.

At the same time, the daily trading volume fell by 13%. This was likely due to the uncertainty around Bitcoin as the leading crypto asset fell to the $85.7k area on Monday and struggled to recover.

Mantle [MNT] has outperformed Bitcoin (down 5.55% in a week), but is this a sustainable trend? AMBCrypto looked into the price charts to find out.

Solving the Mantle trader dilemma

Source: MNT/USDT on TradingView

The daily chart’s technical indicators were encouraging. The DMI showed a strong uptrend in progress, with both its ADX (yellow) and +DI (green) above 20.

The CMF had also been above +0.05 over the past week to show sizeable capital inflows, though this has slowed down a bit.

Structure-wise, MNT bulls had reason to be hopeful.

While the $1.375 swing high remained unbeaten, the internal structure has shifted bullishly. This could set up a breakout.

Source: MNT/USDT on TradingView

The 1-hour chart also showed a bullish structure. Mantle has slowed down after its rally from the 5th to the 13th of December, and found support at the $1.24 area. The DMI showed a strong trend was not in place.

The CMF’s -0.08 reading indicated elevated selling pressure in this lower timeframe.

Putting the clues together

This situation is not easy to resolve. There is market-wide fear and a wobbly Bitcoin [BTC], and MNT is trending in December.

The swing structure was not yet bullish, with $1.375 being a key resistance. Until it is breached, bears have reason to maintain their bias.

Traders’ call to action – MNT traders need to wait for THIS…

The daily timeframe showed steady capital inflows and a bullish shift in December for the altcoin. Bitcoin might climb toward $94k to hunt the liquidity built up there, which could boost short-term MNT sentiment.

Both the bullish and bearish arguments have weight. Based solely on MNT’s price action across timeframes, the bullish scenario is more likely.

A breakout past $1.375 and a subsequent retest as support would offer a buying opportunity.

Traders need to have clear invalidations before looking to go long. For example, a drop below $1.21-$1.23 would spell trouble for the bulls in the short term.


Final Thoughts

  • Mantle has been one of the few top 25 crypto assets to have performed bullishly over the past week.
  • It was approaching a key swing high resistance, and market-wide sentiment did not seem to favor the bulls now.

Disclaimer: The information presented does not constitute financial, investment, trading, or other types of advice and is solely the writer’s opinion

Next: Solana gains institutional access in Brazil – But why is SOL still stuck?

Source: https://ambcrypto.com/mantle-examining-if-mnts-december-strength-can-survive-market-fear/

Market Opportunity
Mantle Logo
Mantle Price(MNT)
$0.77
$0.77$0.77
+1.07%
USD
Mantle (MNT) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26